{"disease":{"id":"hepatitis-c-hcv","name":"hepatitis c hcv"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07388979","title":"MAGIA H3S Point of Care Test Performance for HIV, HBV, HCV, and Syphilis Screening in Pregnant Women in DR Congo","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":7500,"lead_sponsor_name":"Gardiens de Vies","has_results":false},{"nct_id":"NCT05968573","title":"Persuasive Health Communication Intervention for HIV/HCV","phase":"NA","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"University of South Florida","has_results":false},{"nct_id":"NCT07038863","title":"Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT02219490","title":"A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1596,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT03341871","title":"Glecaprevir/Pibrentasvir Drug Use Results Survey in Patients Infected With Hepatitis C Virus Genotype 1-6","phase":"","overall_status":"COMPLETED","enrollment_count":1095,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT05657106","title":"Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":752,"lead_sponsor_name":"April M Young","has_results":false},{"nct_id":"NCT02167945","title":"A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":615,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT01350648","title":"Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection","phase":"","overall_status":"COMPLETED","enrollment_count":569,"lead_sponsor_name":"National Institutes of Health Clinical Center (CC)","has_results":false},{"nct_id":"NCT07122219","title":"Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons","phase":"NA","overall_status":"RECRUITING","enrollment_count":548,"lead_sponsor_name":"McGill University Health Centre/Research Institute of the McGill University Health Centre","has_results":false},{"nct_id":"NCT03222583","title":"A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":546,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT03201718","title":"A Study of Viekira/Exviera for Korean Hepatitis C Patients According to the Standard for Re-examination of New Drugs","phase":"","overall_status":"COMPLETED","enrollment_count":505,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT03089944","title":"A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated Cirrhosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":343,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT07433985","title":"California MEPS Hub","phase":"NA","overall_status":"RECRUITING","enrollment_count":318,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT04903626","title":"Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":286,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT05904470","title":"A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCV","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":275,"lead_sponsor_name":"Atea Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03212521","title":"Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":230,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT03092375","title":"Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":177,"lead_sponsor_name":"University of Florida","has_results":true},{"nct_id":"NCT03214679","title":"Accessible HCV Care Intervention for People Who Inject Illicit Drugs (PWID)","phase":"NA","overall_status":"COMPLETED","enrollment_count":167,"lead_sponsor_name":"City University of New York, School of Public Health","has_results":true},{"nct_id":"NCT03235349","title":"Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT03067129","title":"A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":129,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT03111108","title":"Efficacy and Safety of Elbasvir (MK-8742) + Grazoprevir (MK-5172) in Treatment-Naïve/Treatment-Experienced (TN/TE) French Participants With Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection (MK-5172-096)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":117,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT02609659","title":"Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT02517528","title":"ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-Administered With Ribavirin (RBV) in Treatment Naïve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":104,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT03069365","title":"A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal Impairment","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT02692703","title":"A Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT03219216","title":"A Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT04352309","title":"Efficacy Study Of Oral Glecaprevir/Pibrentasvir Tablet In Pediatric (12 Years and Older) And Adult Treatment-Naive Participants With Chronic Hepatitis C Genotypes 1 To 6 And Liver Cirrhosis","phase":"","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT04189627","title":"A Study of the Effectiveness and Clinical Practice Use of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Genotypes 1 to 6 in Russian Federation","phase":"","overall_status":"COMPLETED","enrollment_count":99,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT04366973","title":"A Study Describing the Care Cascade and Effectiveness and Safety of Glecaprevir/Pibrentasvir in Adult Participants With Hepatitis C Virus in French Addiction Centers","phase":"","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT02966795","title":"A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":84,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT05413785","title":"Hepatitis C Treatment in Probation and Parole Office","phase":"NA","overall_status":"COMPLETED","enrollment_count":77,"lead_sponsor_name":"Jens Rosenau","has_results":false},{"nct_id":"NCT03801707","title":"Utilization of Hepatitis C Positive Kidneys in Negative Recipients","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Ohio State University","has_results":true},{"nct_id":"NCT06799702","title":"Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inject Drugs in the Deep South (Pilot Testing: Aim3)","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":50,"lead_sponsor_name":"University of Georgia","has_results":false},{"nct_id":"NCT04214028","title":"A Study of the Safety, Effectiveness and Clinical Use of Maviret in Adolescent Patients With Chronic Hepatitis C Virus","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT06623058","title":"Accupower ® HCV Performance Evaluation Quant Kit Bioneer Existation™FA 96/384","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":45,"lead_sponsor_name":"CerbaXpert","has_results":false},{"nct_id":"NCT04577482","title":"Study of Oral Glecaprevir/Pibrentasvir Tablets in Participants Aged 12 Years or Older With Chronic Hepatitis C to Assess Sustained Virological Response","phase":"","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT03002818","title":"Quality of Life Measurement in Treatment Naïve Patients With Hepatitis C Virus (HCV) Genotype 1 (GT1) Suffering From Fatigue and Receiving Ombitasvir, Paritaprevir, and Ritonavir and Dasabuvir (Viekirax®/Exviera®)","phase":"","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT03549312","title":"Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":25,"lead_sponsor_name":"Saskatchewan Health Authority - Regina Area","has_results":false},{"nct_id":"NCT02487199","title":"Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT01707472","title":"Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT04513899","title":"Development of a Community-based HCV Treatment Completion Intervention Among HCV Positive Homeless Adults","phase":"NA","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"University of California, Irvine","has_results":true},{"nct_id":"NCT04019717","title":"Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Atea Pharmaceuticals, Inc.","has_results":false}],"total":42},"guidelines":[],"source":"Drug Landscape verified database"}